Moderna Inc (MRNA)
104.31
+0.46
(+0.44%)
USD |
NASDAQ |
Apr 16, 14:27
Moderna Free Cash Flow: -3.825B for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.825B |
| September 30, 2023 | -2.657B |
| June 30, 2023 | -754.00M |
| March 31, 2023 | 612.00M |
| December 31, 2022 | 4.581B |
| September 30, 2022 | 6.201B |
| June 30, 2022 | 9.215B |
| March 31, 2022 | 13.03B |
| December 31, 2021 | 13.34B |
| September 30, 2021 | 11.39B |
| June 30, 2021 | 9.083B |
| Date | Value |
|---|---|
| March 31, 2021 | 5.007B |
| December 31, 2020 | 1.959B |
| September 30, 2020 | 612.84M |
| June 30, 2020 | -374.97M |
| March 31, 2020 | -451.14M |
| December 31, 2019 | -491.00M |
| September 30, 2019 | -489.50M |
| June 30, 2019 | -482.04M |
| March 31, 2019 | -445.20M |
| December 31, 2018 | -436.63M |
Free Cash Flow Range, Past 5 Years
-3.825B
Minimum
Dec 2023
13.34B
Maximum
Dec 2021
3.447B
Average
612.84M
Median
Sep 2020
Free Cash Flow Benchmarks
| Eli Lilly and Co | -3.152B |
| Merck & Co Inc | 9.143B |
| Pfizer Inc | 4.793B |
| Johnson & Johnson | 17.78B |
| Novavax Inc | -772.77M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 622.00M |
| Cash from Investing (Quarterly) | -538.00M |
| Cash from Financing (Quarterly) | -109.00M |
| Free Cash Flow Per Share (Quarterly) | 1.052 |
| Free Cash Flow to Equity (Quarterly) | 402.00M |
| Free Cash Flow to Firm (Quarterly) | 402.00M |
| Free Cash Flow Yield | -9.47% |